The article under consideration, “Antibody Responses in COVID-19 Patients,” written by Liu & Lu, aims to review and analyze the studies’ findings and present the patterns of interactions between the immune system and corresponding pathogens. The authors’ conclusions are intended for specialists working on the development of vaccines against COVID-19 as well as any other similar infections. The antibody responses to this virus were confirmed to be complex, and the severity of cases affects treatment outcomes.
The study used the reports of other scholars on antibody responses, and their consideration allowed distinguishing specific unique mechanisms of action. Thus, both S and N proteins can be targeted, and IgM and IgG responses are usually revealed at the early stages of the disease progression (Liu & Lu, 2020). In turn, the more complicated the case is, the higher levels of antibodies are detected (Liu & Lu, 2020). Meanwhile, the long-lasting response of this infection was not confirmed, whereas immune protection ensured by the development of vaccines is still applicable (Liu & Lu, 2020). Therefore, the researchers proved the feasibility of elaborating preventing measures while focusing on the described mode of action.
The presented information connects to pathophysiology by providing specialists with the basic knowledge of this disease’s course. In other words, the established responses, which can be revealed early, allow for taking timely measures to eliminate patient risks. In this situation, the protective effects of antibodies can be both direct and indirect, and the environmental conditions can be analyzed to show the correlation between severe cases of COVID-19 and its mild forms (Liu & Lu, 2020). Also, the relevance of this article is conditional upon the contradictory evidence of previous research, and the efforts of the scholars allow relying on the typical findings for elaborating further practices.
Reference
Liu, S., & Lu, S. (2020). Antibody responses in COVID-19 patients.Journal of Biomedical Research, 34(6), 410-415.